← Back to Search

N95 Style Transparent Face Mask

Transparent Face Masks for Respiratory Protection

N/A
Waitlist Available
Led By Peter Chai, MD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients must be over 18 years old
No history of asthma, restrictive lung disease, interstitial lung disease, or emphysema
Must not have
Patients must be less than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after completion of all three arms
Awards & highlights
No Placebo-Only Group

Summary

"This trial will test the feasibility and acceptability of two new transparent face masks, the SEEUS-95 mask and CrystalGuard mask, which are designed to protect against respiratory pathogens like COVID-19.

Who is the study for?
This trial is for individuals who are interested in testing the feasibility and acceptability of two new transparent face masks designed to protect against respiratory pathogens like COVID-19. Specific eligibility criteria were not provided.
What is being tested?
The study is comparing the traditional N95 face mask with two novel transparent masks: CrystalGuard Mask and SEEUS95 Transparent mask, to assess their effectiveness and user experience.
What are the potential side effects?
Potential side effects may include discomfort, skin irritation, or difficulty breathing due to mask fit. However, specific side effects related to these particular masks have not been detailed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.
Select...
I have never had asthma or serious lung diseases.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after mask wearing
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after mask wearing for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Secondary study objectives
Mask preference

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: SEEUS95Experimental Treatment1 Intervention
Transparent mask developed by SEEUS95
Group II: CrystalGuardExperimental Treatment1 Intervention
Transparent mask developed at BWH
Group III: N95Active Control1 Intervention
Standard N95 face mask

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,670 Previous Clinical Trials
11,878,226 Total Patients Enrolled
Peter Chai, MDPrincipal InvestigatorBrigham and Women's Hospital
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top